Clinical Trials Sponsored by Bin Cai

Total 7925 results

Bin Cao

Unknown

Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria

Bronchiectasis | Non-tuberculous Mycobacterial

China
Bin Cai

Recruiting

Cerebral Small Vessel Disease Registry Study

Cerebral Small Vessel Diseases

China
Bin Cai

Recruiting

CADASIL Registry Study

Cadasil

China
Bin Cao
BioMérieux

Unknown

The Clinical Value of FA in AHLRI Patients (FALRI)

Lower Respiratory Tract Infection

China
Xin Cai

Not yet recruiting

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Rectal Cancer | Recurrent

China
BIO-CAT, Inc.
McGill University

Completed

Effects of Microbial Protease Supplementation on Postprandial Plasma Amino Acid Concentrations and Appetite

Appetitive Behavior | Gastrointestinal Health | Digestive Health

Canada
BIO-CAT Inc.
Atlantia Food Clinical Trials; Cork University Hospital

Completed

Effect of Candida Rugosa Lipase on Serum Triglyceride Lowering

Hypertriglyceridemia

Ireland
Cheung Chi Wai

Completed

Electronic Visual Analogue Scale in Acute Postoperative Pain

Post-operative Pain

China
CAI Hongbing

Recruiting

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Ovarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer, Epithelial | Hyperthermic Intraperitoneal Chemotherapy(HIPEC) | Homologous Recombination Repair Gene Mutation

China
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

Bloating

United States, Canada
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

Elevated Triglycerides

Canada
BIO-CAT Microbials, LLC
Prism Research LLC

Completed

Safety and Tolerability of Bacillus Subtilis MB40 in Healthy Adult Volunteers

Healthy Participants
Dr. Cuong Tran Chi

Recruiting

Rescue Extracranial Vertebral Stenting in Tandem Occlusions (REVET)

Acute Stroke | Ischemic Stroke, Acute | Vertebro Basilar Ischemia

Vietnam
Kwan-Hwa Lin
Buddhist Tzu Chi General Hospital

Completed

Strategy for Daily Activity Improvement in Patients With Parkinson's Disease (Parkinson)

Parkinson Disease

Taiwan
BIO-CAT Microbials, LLC
Biofortis Clinical Research, Inc.

Completed

Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults

Immune Health | Cardiovascular Health | Gastrointestinal Health | Digestive Health

United States
Xueli Cai

Recruiting

Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion (START)

Stroke | Thrombectomy | Tandem Occlusion

China
Prince Sattam Bin Abdulaziz University
Princess Nourah Bint Abdulrahman University

Completed

Integrated Physical Training With Protein Diet in Older Adults With Sarcopenia Symptoms.

Sarcopenia

Saudi Arabia
University of Illinois at Urbana-Champaign
BIO-CAT, Inc.

Completed

Microbial Enzyme Impact on Postprandial Nutrient Levels and Gastrointestinal Symptoms in Healthy Adults (BIO-3003)

Gastrointestinal Health | Digestive Health

United States
BIO-CAT, Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Safety and Tolerability Trial of Microbial Inulinase

Gastrointestinal Health | Digestive Health

Canada
University of Illinois at Urbana-Champaign
BIO-CAT, Inc.

Completed

Effect of Microbial Protease Supplementation on Postprandial Amino Acid Levels

Protein Metabolism

United States
Our Lady of Maryknoll Hospital
Wong Tai Sin Hospital

Unknown

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers

Pressure Ulcers Stage III | Pressure Ulcer, Stage IV

Hong Kong
Yin-ku Lin

Completed

Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis

Psoriasis Vulgaris

Taiwan
Viela Bio
CTI Clinical Trial and Consulting Services

Terminated

A Phase1 Study of VIB9600

Safety Issues

United States
TWGHs Wong Tai Sin Hospital
The Hong Kong Polytechnic University

Not yet recruiting

Effectiveness of Computer-based Cognitive Training for Executive Functions After Stroke

Stroke | Cognitive Impairment | Executive Dysfunction | Randomized Controlled Trial
CTI BioPharma

Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin (RAPID)

Diffuse Large-Cell Lymphoma

United States, Germany, Canada, Italy, France
SCAI Therapeutics

Completed

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Dry Eye Syndromes

Korea, Republic of
CTI BioPharma

Completed

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia

United States
CTI BioPharma

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (PIX-R)

Diffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 Lymphoma

United States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
CTI BioPharma

Terminated

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. (PIONEER)

NSCLC

United States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
CTI BioPharma

Terminated

Arsenic Trioxide in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
CTI BioPharma

Terminated

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

Canada, United States
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
KAI Pharmaceuticals

Completed

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Secondary Hyperparathyroidism
KAI Pharmaceuticals

Completed

Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack

Myocardial Infarction

United States
CTI BioPharma

Completed

Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

Colorectal Cancer

Italy
Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac...

Recruiting

Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure (AALARA)

Tachycardia, Supraventricular

Bahrain
Sarah Emad Ali El-Din

Unknown

Comparing Bond Strength,Microleakage and Clinical Performance of Three Pit and Fissure Sealants

Caries Prevention

Egypt
Cai Kailin

Unknown

A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery

Locally Advanced Gastric Cancer

China
CTI BioPharma

Terminated

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

COVID-19 | COVID | COVID19

United States
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia (PAC326)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
CTI BioPharma

Terminated

CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy

Prostate Cancer

United States
CTI BioPharma

Withdrawn

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

NSCLC

United States
CTI BioPharma

Withdrawn

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

Non-Hodgkin's Lymphoma

United States
CTI BioPharma

Terminated

Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

United States
KAI Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism, Secondary

United States, Australia
CTI BioPharma

Terminated

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

Lymphoma, Follicular | Lymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-Grade

United States
CLI Foundation

Unknown

Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction (COCTAIL II)

ST-elevation Myocardial Infarction

Italy
CTI BioPharma

Completed

Phase II CT-2103/Carboplatin in Ovarian Cancer

Ovarian Neoplasm

United States

Clinical Trials Sponsored by Bin Cai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations